-+ 0.00%
-+ 0.00%
-+ 0.00%

Ascendiant Capital Maintains Buy on Aemetis, Lowers Price Target to $18

Benzinga·11/16/2026 11:27:47
Listen to the news
Ascendiant Capital analyst Edward Woo maintains Aemetis (NASDAQ:AMTX) with a Buy and lowers the price target from $20 to $18.